[6R]-MTHF IN B6 ENHANCED 5-FU BASED CHEMOTHERAPY OF CARCINOMA

The present invention relates to the treatment of carcinoma, such as colorectal cancer, in human populations employing a dosage regimen which includes arfolitixorin, i.e. [6R]-5,10-methylenetetrahydrofolate ([6R]-MTHF) and a vitamin B6 in connection with 5-fluorouracil (5-FU) based chemotherapy.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Machover, David, Lindberg, Per Lennart
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the treatment of carcinoma, such as colorectal cancer, in human populations employing a dosage regimen which includes arfolitixorin, i.e. [6R]-5,10-methylenetetrahydrofolate ([6R]-MTHF) and a vitamin B6 in connection with 5-fluorouracil (5-FU) based chemotherapy.